International Journal of Hematology

, Volume 91, Issue 2, pp 338–339 | Cite as

Non-cirrhotic extrahepatic portal vein thrombosis: a 6-year long case history

  • Giorgio Ricci
  • Flavia Pigò
  • Angelo Rossi
  • Gianluca Bersani
  • Vittorio Alvisi
Letter to the Editor
  • 61 Downloads

References

  1. 1.
    Webster GJM, Burroughs AK, Riordan SM. A review article: portal vein thrombosis, new insights into etiology and management. Aliment Pharmacol Ther. 2005;21:1–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis. 2006;10:627–51.CrossRefPubMedGoogle Scholar
  3. 3.
    Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Cancer genome project: acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.PubMedGoogle Scholar
  4. 4.
    Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–90.CrossRefPubMedGoogle Scholar
  6. 6.
    P’ng S, Carnley B, Baker R, Kontorins N, Cheng W. Undiagnosed myeloprolipherative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation. Clin Gastroenterol Hepatol. 2008;6:472–5.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2010

Authors and Affiliations

  • Giorgio Ricci
    • 1
  • Flavia Pigò
    • 1
  • Angelo Rossi
    • 2
  • Gianluca Bersani
    • 2
  • Vittorio Alvisi
    • 1
  1. 1.Department of Clinical and Experimental Medicine, GastroenterologyUniversity of FerraraFerraraItaly
  2. 2.Digestive Endoscopy ServiceMalatesta Novello HospitalCesenaItaly

Personalised recommendations